The APT e-Guidelines cover the 2024 CCS/CAIC Guidelines for the Use of Antiplatelet Therapy Update. This update to the 2011 and 2013 Antiplatelet Therapy Guidelines incorporates new evidence on how to optimally use antiplatelet therapy, particularly in conditions which few to no data were previously … See more Learn about key topics in Heart Failure as well as Atrial Fibrillation, Dyslipidemia, and Antiplatelet Therapy See more Additional guideline tools and resources including pocket guides, educational videos, slide decks and our very popular iCCS Guideline apps … See more 1. Bell AD, Roussin A, Cartier R, et al. The use of antiplatelet therapy in the outpatient setting: Canadian Cardiovascular Society guidelines. Can J Cardiol 2011;27 Suppl A:S1-59. 2. Tanguay … See more The CCS has developed specific policies and procedures to ensure that our guidelines are high quality and transparent. Guideline development is overseen by the CCS … See more WebAug 26, 2024 · ESC Guidelines on Dual Antiplatelet Therapy (DAPT) Focused update on Dual Antiplatelet Therapy (DAPT) Guidelines ESC Clinical Practice Guidelines 26 Aug 2024 Guidelines and related materials are for use by individuals for personal or educational purposes. No commercial use is allowed. Re-use permission must be correctly obtained …
Anticoagulation and Antiplatelet Therapy in Urologic …
WebSep 6, 2024 · The choice of anti-ischemic drugs to treat CCS should be adapted to the patient’s heart rate, blood pressure, and LV function. Beta-blockers and/or calcium … WebNov 17, 2024 · The 2024 CCS AF guidelines recommend evidence-based beta-blockers (bisoprolol, carvedilol, metoprolol) be first-line agents for rate control of AF in patients with significant LV dysfunction (LV ejection fraction of 40% or less; Strong Recommendation; Moderate-Quality Evidence). the little engine that could jebediah
Focused 2012 Update of the Canadian Cardiovascular Society …
WebAntiplatelet therapy has formed the backbone of ACS management for decades and the drug class continues to evolve as novel agents with increasingly efficacious antiplatelet … WebSep 30, 2024 · Aimed to evaluate and compare the interactive effects of different antiplatelet or anticoagulation strategies in patients with chronic coronary syndromes (CCS) after percutaneous coronary intervention (PCI). Randomized controlled trials comparing different antiplatelet or anticoagulant strategies in patients with CCS after PCI were … WebApr 1, 2024 · Antiplatelet therapy is key to reducing local thrombotic complications and systemic ischaemic events among patients undergoing percutaneous coronary interventions (PCI), but it is inevitably associated with increased bleeding. ... (CCS), antiplatelet therapy reduces the occurrence of intraprocedural or very early stent thrombosis (right ... ticketportal olomouc